Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oscar Selvaggio

Showing results (31-40 of 44) with videos related to

Pageof 5
Sort By:
Frontiers in Oncology|January 25, 2021
Does Multiparametric Magnetic Resonance of Prostate Outperform Risk Calculators in Predicting Prostate Cancer in Biopsy Naïve Patients?Ugo Giovanni Falagario, Giovanni Silecchia, Salvatore Mariano Bruno, et al.
Journal of Clinical Medicine|September 9, 2023
External Validation of the IMPROD-MRI Volumetric Model to Predict the Utility of Systematic Biopsies at the Time of Targeted BiopsyAntonella Ninivaggi, Francesco Guzzi, Alessio Degennaro, et al.
Central European Journal of Urology|November 3, 2021
Bioptic prostatic inflammation correlates with false positive rates of multiparametric magnetic resonance imaging in detecting clinically significant prostate cancerUgo Giovanni Falagario, Marco Recchia, Giovanni Silecchia, et al.
Urology Case Reports|April 8, 2026
Allium® bulbar urethral stent (BUS) for severe recurrent urethral stricture in a renal transplant recipient: a minimally invasive graft-preserving solutionNicola Schiavone, Marco Finati, Anna Ricapito, et al.
International Urology and Nephrology|February 22, 2023
Treatment of localized prostate cancer in elderly patients: the role of partial cryoablationOscar Selvaggio, Marco Finati, Ugo Giovanni Falagario, et al.
International Journal of Molecular Sciences|February 11, 2023
Foggia Prostate Cancer Risk Calculator 2.0: A Novel Risk Calculator including MRI and Bladder Outlet Obstruction Parameters to Reduce Unnecessary BiopsiesUgo Giovanni Falagario, Gian Maria Busetto, Marco Recchia, et al.
Cancer Research|June 22, 2014
Pentraxin 3: a novel biomarker for predicting progression from prostatic inflammation to prostate cancerGiovanni Stallone, Luigi Cormio, Giuseppe Stefano Netti, et al.
Diagnostics (Basel, Switzerland)|February 25, 2022
One-Day Prostate Cancer Diagnosis: Biparametric Magnetic Resonance Imaging and Digital Pathology by Fluorescence Confocal MicroscopyUgo Giovanni Falagario, Oscar Selvaggio, Francesca Sanguedolce, et al.
Scientific Reports|October 28, 2020
Modulation of complement activation by pentraxin-3 in prostate cancerGiovanni Stallone, Giuseppe Stefano Netti, Luigi Cormio, et al.
Cancers|September 10, 2021
Intraoperative Digital Analysis of Ablation Margins (DAAM) by Fluorescent Confocal Microscopy to Improve Partial Prostate Gland Cryoablation OutcomesOscar Selvaggio, Ugo Giovanni Falagario, Salvatore Mariano Bruno, et al.
Pageof 5

Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
Frontiers in Oncology|January 25, 2021
Does Multiparametric Magnetic Resonance of Prostate Outperform Risk Calculators in Predicting Prostate Cancer in Biopsy Naïve Patients?Ugo Giovanni Falagario, Giovanni Silecchia, Salvatore Mariano Bruno, et al.
Journal of Clinical Medicine|September 9, 2023
External Validation of the IMPROD-MRI Volumetric Model to Predict the Utility of Systematic Biopsies at the Time of Targeted BiopsyAntonella Ninivaggi, Francesco Guzzi, Alessio Degennaro, et al.
Central European Journal of Urology|November 3, 2021
Bioptic prostatic inflammation correlates with false positive rates of multiparametric magnetic resonance imaging in detecting clinically significant prostate cancerUgo Giovanni Falagario, Marco Recchia, Giovanni Silecchia, et al.
Urology Case Reports|April 8, 2026
Allium® bulbar urethral stent (BUS) for severe recurrent urethral stricture in a renal transplant recipient: a minimally invasive graft-preserving solutionNicola Schiavone, Marco Finati, Anna Ricapito, et al.
International Urology and Nephrology|February 22, 2023
Treatment of localized prostate cancer in elderly patients: the role of partial cryoablationOscar Selvaggio, Marco Finati, Ugo Giovanni Falagario, et al.
International Journal of Molecular Sciences|February 11, 2023
Foggia Prostate Cancer Risk Calculator 2.0: A Novel Risk Calculator including MRI and Bladder Outlet Obstruction Parameters to Reduce Unnecessary BiopsiesUgo Giovanni Falagario, Gian Maria Busetto, Marco Recchia, et al.
Cancer Research|June 22, 2014
Pentraxin 3: a novel biomarker for predicting progression from prostatic inflammation to prostate cancerGiovanni Stallone, Luigi Cormio, Giuseppe Stefano Netti, et al.
Diagnostics (Basel, Switzerland)|February 25, 2022
One-Day Prostate Cancer Diagnosis: Biparametric Magnetic Resonance Imaging and Digital Pathology by Fluorescence Confocal MicroscopyUgo Giovanni Falagario, Oscar Selvaggio, Francesca Sanguedolce, et al.
Scientific Reports|October 28, 2020
Modulation of complement activation by pentraxin-3 in prostate cancerGiovanni Stallone, Giuseppe Stefano Netti, Luigi Cormio, et al.
Cancers|September 10, 2021
Intraoperative Digital Analysis of Ablation Margins (DAAM) by Fluorescent Confocal Microscopy to Improve Partial Prostate Gland Cryoablation OutcomesOscar Selvaggio, Ugo Giovanni Falagario, Salvatore Mariano Bruno, et al.
Pageof 5